Old HIV drugs get a second look in Long-Term study
NCT ID NCT01125228
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study looked at three treatments for people with early HIV infection: zidovudine (AZT) alone, interferon alone, or both together. The goal was to see which worked best to lower the amount of virus in the blood, protect the immune system, and delay the first serious infection. About 180 adults with healthy immune systems (CD4 count of 500 or higher) took part. The study is now in long-term follow-up to track health outcomes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.